Hawaii Subject | Temporary Breakthrough Therapy Designation Advisory Council

Filter View [Reset All]
Syndicate content
StanceStateBillStatusSummary/TitleLast Actionsort icon
HIHB1340Engross
50%
Requires the Director of Health to establish a Temporary Breakthrough Therapy Designation Advisory Council within 3 months of certain breakthrough therapy designation approvals by the United States Food and Drug Administration. (SD2)
[Detail][Text][Discuss]
2024-03-25
Received notice of discharge of all conferees (Hse. Com. No. 457).
Syndicate content
feedback